These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4921235)

  • 21. Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Kato H; Takemura S; Kondo M
    Haemostasis; 1983; 13(6):374-8. PubMed ID: 6667905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstructive jaundice. Renal failure and other endotoxin-related complications.
    Cahill CJ; Pain JA
    Surg Annu; 1988; 20():17-37. PubMed ID: 3283963
    [No Abstract]   [Full Text] [Related]  

  • 23. STUDY OF THE ANTI-THROMBOTIC PROPERTIES OF DEXTRANS OF LARGE MOLECULAR WEIGHT.
    BRYANT MF; BLOOM WL; BREWER SS
    J Cardiovasc Surg (Torino); 1964; 5():48-52. PubMed ID: 14109832
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of superoxide dismutase and catalase on disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Yoshida N; Seto O; Kondo M
    Thromb Haemost; 1983 Dec; 50(4):869-72. PubMed ID: 6665768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications in obstructive jaundice: role of endotoxins.
    Greve JW; Gouma DJ; Buurman WA
    Scand J Gastroenterol Suppl; 1992; 194():8-12. PubMed ID: 1298053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [STUDIES ON THE THROMBIN TEST IN LIVER AND BILIARY TRACT DISEASES].
    SONODA N
    Iryo; 1964 Jul; 18():439-44. PubMed ID: 14196266
    [No Abstract]   [Full Text] [Related]  

  • 27. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic hypotension and renal failure in obstructive jaundice-mechanistic and therapeutic aspects.
    Green J; Better OS
    J Am Soc Nephrol; 1995 May; 5(11):1853-71. PubMed ID: 7620083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired dysfibrinogenaemia in liver disease.
    Francis JL; Armstrong DJ
    J Clin Pathol; 1982 Jun; 35(6):667-72. PubMed ID: 7085917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatorenal syndrome associated with obstructive jaundice.
    Nanji AA; Scudamore CH; Filipenko JD; Owen DA
    J Clin Gastroenterol; 1985 Oct; 7(5):431-3. PubMed ID: 4067231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of endotoxemia on hepatic energy metabolism in rats with obstructive jaundice.
    Takada T; Yasuda H; Yamakawa Y; Ando H; Bulkley GB; Kamano T
    Hepatogastroenterology; 1996; 43(10):914-8. PubMed ID: 8884313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
    Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [STUDIES ON THE RELATIONS BETWEEN VASCULAR AND BLOOD COAGULATION FACTORS IN THE SANARELLI-SHWARTZMAN PHENOMENON].
    MUELLER-BERGHAUS G; LASCH HG
    Thromb Diath Haemorrh; 1963 Jul; 143():335-45. PubMed ID: 14081257
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and experimental study on hepatorenal syndrome in terms of obstructive jaundice (author's transl)].
    Kasai Y; Kawanishi N
    Hokkaido Igaku Zasshi; 1978; 53(2):147-55. PubMed ID: 352884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of single and repeated hemodialises on the blood coagulation status].
    Albert FW; Kreiter H
    Munch Med Wochenschr; 1972 Nov; 114(44):1917-21. PubMed ID: 4678729
    [No Abstract]   [Full Text] [Related]  

  • 36. Short-time rabbit model of endotoxin-induced hypercoagulability.
    Scherer RU; Giebler RM; Schmidt U; Paar D; Wüst T; Spangenberg P; Militzer K; Hirche H; Kox WJ
    Lab Anim Sci; 1995 Oct; 45(5):538-46. PubMed ID: 8569153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice.
    Wilkinson SP; Moodie H; Stamatakis JD; Kakkar VV; Williams R
    Br Med J; 1976 Dec; 2(6049):1415-8. PubMed ID: 795499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and clinical studies on renal disturbance in obstructive jaundice.
    Koyama K; Ito K; Fukaya H; Okabe K; Sato T
    Jpn J Surg; 1981; 11(6):440-8. PubMed ID: 7328937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endotoxemic acute renal failure in awake rats.
    Kikeri D; Pennell JP; Hwang KH; Jacob AI; Richman AV; Bourgoignie JJ
    Am J Physiol; 1986 Jun; 250(6 Pt 2):F1098-106. PubMed ID: 3521325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.